Complement cascade gene expression defines novel prognostic subgroups of acute myeloid leukemia.

[1]  E. Gottlin,et al.  Complement Factor H Antibodies from Lung Cancer Patients Induce Complement-Dependent Lysis of Tumor Cells, Suggesting a Novel Immunotherapeutic Strategy , 2015, Cancer Immunology Research.

[2]  S. Mamidi,et al.  Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells , 2015, Oncoimmunology.

[3]  Ulrich Mansmann,et al.  Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis. , 2014, Blood.

[4]  B. Wollenberg,et al.  The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack. , 2014, European journal of cancer.

[5]  K. Baggerly,et al.  Autocrine Effects of Tumor-Derived Complement , 2014, Cell reports.

[6]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[7]  Ulrich Mansmann,et al.  Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Angelo J. Canty,et al.  Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.

[9]  John D Lambris,et al.  Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.

[10]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[11]  John D Lambris,et al.  Is complement good or bad for cancer patients? A new perspective on an old dilemma. , 2009, Trends in immunology.

[12]  M. Ratajczak,et al.  DEFECTIVE ENGRAFTMENT OF C3aR-/- HEMATOPOIETIC STEM PROGENITOR CELLS REVEALS A NOVEL ROLE OF THE C3a-C3aR AXIS IN BONE MARROW HOMING , 2009, Leukemia.

[13]  Bas J. Wouters,et al.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling , 2009, Haematologica.

[14]  J. Itskovitz‐Eldor,et al.  CD133‐Positive Hematopoietic Stem Cell “Stemness” Genes Contain Many Genes Mutated or Abnormally Expressed in Leukemia , 2005, Stem cells.

[15]  Gerard Brady,et al.  Routine expression profiling of microarray gene signatures in acute leukaemia by real‐time PCR of human bone marrow * , 2005, British journal of haematology.

[16]  John D Lambris,et al.  Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. , 2003, Blood.

[17]  S. Meri,et al.  Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells , 2002, British Journal of Cancer.

[18]  E. Kitano,et al.  Synthesis of factor D by gastric cancer-derived cell lines. , 2002, International immunopharmacology.